Results 71 to 80 of about 397 (134)

New trends in the treatment of androgenetic alopecia

Przegląd Dermatologiczny
Androgenetic alopecia is the most common form of non-cicatricial hair loss, affecting a significant proportion of the population, particularly men.
Szymon Leonik, Michał Smoczok, Beata Bergler-Czop   +2 more
doaj   +1 more source

Platelet-rich plasma therapy in the treatment of androgenic alopecia – review

Journal of Education, Health and Sport
Hair loss is a problem that affects many people around the world. Androgenic alopecia (AGA) is the most common cause of hair loss affecting up to 50% of men and 40% of women over the age of 50.
Beata Getka, Kinga Przyborowska, Mateusz Rukat, Michał Łata, Justyna Kwiecień, Katarzyna Wiejak   +5 more
doaj   +1 more source

In vitro 5α-reductase inhibition by selected Ayurvedic herbs for androgenic disorders

International Journal of Ayurveda Research
Background: Androgenic disorders such as androgenic alopecia is driven by elevated Dihydrotestosterone (DHT) levels, which are regulated by the enzyme 5α-reductase.
Anirban Kr Chakrabarty, Dipankar Banerjee, Rajiva Kumar Rai, Chandra Kant Katiyar, Sunil Kumar Dubey   +4 more
doaj   +1 more source

Comparative Study of a Topical and Oral Combination Therapy Containing Oleanolic Acid, Apigenin, and Biotinyl Tripeptide-1 in Patients with Androgenetic Alopecia: A Prospective, Open-Label Trial

Cosmetics
Background: Androgenetic alopecia (AGA) is a prevalent condition characterized by progressive follicular miniaturization. Minoxidil topical treatment and finasteride oral treatment are the golden standard, but they are limited by local and systemic ...
Vlad-Mihai Voiculescu, Mihai Lupu
doaj   +1 more source

Androgenic alopecia updates

International Journal of Dermatology, Venereology and Leprosy Sciences, 2023
Hadeel Ibrahem Ali Helaly, Lamia Hamouda El Garhy, Dareen Abdel Aziz Mohammed, Nahla Elsayed Ramzy   +3 more
openaire   +1 more source

Alopecia

Journal of Health Science and Medical Research (JHSMR), 2008
Alopecia or baldness is a common problem that can cause worry and stress to patients. The evaluation of hair loss remains a difficult and confusing subject for most physicians.
S Thaichinda
doaj  

THE ROLE OF ESTROGEN IN WOMEN WITH ANDROGENETIC ALOPECIA

e-Jurnal Medika Udayana, 2013
Hair loss may accured in both male and female population. Hair loss usually accured in Telogenic phase, meanwhile in Anagenic phase hair loss due to chemotherapy or radiation.
Putu Diah Pratiwi, IGN Sri Wiryawan, Ni Made Linawati, Ni Luh Mas Rusyati   +3 more
doaj  

Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia

International Journal of Nanomedicine, 2014
Rehab Nabil Shamma, Mona Hassan AburahmaDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, EgyptAbstract: Spironolactone (SL) is a US Food and Drug Administration-approved drug for the treatment of ...
Shamma RN, Aburahma MH
doaj  

Shame and self-esteem in androgenic alopecia patients

Przegląd Dermatologiczny, 2021
Joanna Furmańska, Ryszard Żaba, Teresa Rzepa, Przemysław Kubaszewski   +3 more
doaj   +1 more source

The impact of oxidative stress in the androgenic alopecia in women

Advances in Dermatology and Allergology, 2020
Cwynar, Anna, Olszewska-Słonina, Dorota M., Czajkowski, Rafał   +2 more
openaire   +2 more sources